Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032529 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Husam B R Alabed und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Vascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sickle cell disease (SCD) is one of the most common severe monogenic disorders in the world caused by a mutation on HBB gene and characterized by hemoglobin polymerization, erythrocyte rigidity, vaso-occlusion, chronic anemia, hemolysis, and vasculopathy. Recently, the scientific community has focused on the multiple genetic and clinical profiles of SCD. However, the lipid composition of sickle cells has received little attention in the literature. According to recent studies, changes in the lipid profile are strongly linked to several disorders. Therefore, the aim of this study is to dig deeper into lipidomic analysis of erythrocytes in order to highlight any variations between healthy and patient subjects. 241 lipid molecular species divided into 17 classes have been annotated and quantified. Lipidomic profiling of SCD patients showed that over 24% of total lipids were altered most of which are phospholipids. In-depth study of significant changes in lipid metabolism can give an indication of the enzymes and genes involved. In a systems biology scenario, these variations can be useful to improve the understanding of the biochemical basis of SCD and to try to make a score system that could be predictive for the severity of clinical manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy.
- Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
- Pediatric Oncology-Hematology, Azienda Ospedaliera di Perugia, 06100 Perugia, Italy.
- Centro di Eccellenza sui Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.
ORCID-Profile: Husam B R Alabed, Roberto Maria Pellegrino, Hovirag Lancioni, Roberta La Starza, Lorena Urbanelli, Anair Graciela Lema Fernandez
Zitieren
APA
Alabed, H. B. R., Gorello, P., Pellegrino, R. M., Lancioni, H., La Starza, R., Taddei, A. A., Urbanelli, L., Buratta, S., Fernandez, A. G. L., Matteucci, C., Caniglia, M., Arcioni, F., Mecucci, C., & Emiliani, C. (2023). Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032529
Vancouver
Alabed HBR, Gorello P, Pellegrino RM, Lancioni H, La Starza R, Taddei AA, et al. Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032529
BibTeX
@article{Alabed2023,
author = {Alabed, Husam B R and Gorello, Paolo and Pellegrino, Roberto Maria and Lancioni, Hovirag and La Starza, Roberta and Taddei, Anna Aurora and Urbanelli, Lorena and Buratta, Sandra and Fernandez, Anair Graciela Lema and Matteucci, Caterina and Caniglia, Maurizio and Arcioni, Francesco and Mecucci, Cristina and Emiliani, Carla},
title = {Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032529}
}
EUVIMED